Legal Opinion
United States Ex. Rel. Kelly v. Novartis Pharmaceuticals Corp.
Court of Appeals for the First Circuit
Decided June 17, 2016No. 15-1470PPublishedCited by 53 opinions
1Opinion of the Court
STAHL, Circuit Judge.
Appellants Allison Kelly and Frank Garcia (“Relators”) brought qui tam actions against Appellees Genentech, Inc. and Roche Holdings, Inc. (“Genentech”) and Novartis Pharmaceuticals Corporation and Novartis Corporation (“Novartis”) (collectively, “Defendants”) under the False Claims Act (“FCA”), 31 U.S.C. § 3729 et seq., and related state statutes. Relators allege that Defendants caused physicians and healthcare providers to submit false claims to the government for reimbursement for Xolair, an injected drug used to treat allergies.
Because Relators failed to state their…
2Cases cited33 opinions
- Foman v. DavisSupreme Court of the United States · 1962
- Rodi v. Southern New England School of LawCourt of Appeals for the First Circuit · 2004
- Rodriguez-Bruno v. Doral MortgageCourt of Appeals for the First Circuit · 1995
- Bullard v. Blue Hills BankSupreme Court of the United States · 2015
- Boyle v. Hasbro, Inc.Court of Appeals for the First Circuit · 1996
28 more not listed; retrieve them via the Exa API.
3Cited by53 opinions
- Hagerty Ex Rel. United States v. Cyberonics, Inc.Court of Appeals for the First Circuit · 2016
- D'Agostino v. EV3, Inc.Court of Appeals for the First Circuit · 2016
- United States Ex Rel. Booker v. Pfizer, Inc.Court of Appeals for the First Circuit · 2017
- Sexual Minorities Uganda v. LivelyCourt of Appeals for the First Circuit · 2018
- Borras-Borrero v. Corp del Fondo del Seguro delCourt of Appeals for the First Circuit · 2020
48 more not listed; retrieve them via the Exa API.